Park Square Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-116
Closed -$9.27K 298
2025
Q4
$9.27K Buy
+116
New +$11.3K 0.06% 153
2025
Q3
Sell
-197
Closed -$17.2K 679
2025
Q2
$17.2K Sell
197
-118
-37% -$10K 0.01% 497
2025
Q1
$28.3K Buy
315
+31
+11% +$2.77K 0.02% 360
2024
Q4
$22.7K Buy
+284
New +$24.6K 0.02% 401

Other funds holding MDT

Park Square Financial Group's MDT Position: Q1 2026 in Review

Park Square Financial Group sold out of Medtronic (MDT) in Q1 2026, closing a stake of 116 shares — an estimated $9.27K sold.

Park Square Financial Group first reported a position in MDT in Q4 2024 and held it in 4 quarters. The position peaked at $28.3K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Park Square Financial Group reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Park Square Financial Group sold 116 Medtronic shares in Q1 2026, an estimated $9.27K.
  • Park Square Financial Group first reported a position in Medtronic in Q4 2024 and held it in 4 quarters.
  • Park Square Financial Group's Medtronic position peaked at $28.3K in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Park Square Financial Group's 13F filing for Q1 2026, filed 13 May 2026.